These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 20888596)

  • 21. Immunohematologic reconstitution in pediatric patients after T cell-depleted HLA-haploidentical stem cell transplantation for thalassemia.
    Isgrò A; Marziali M; Sodani P; Gaziev J; Erer B; Polchi P; Paciaroni K; Roveda A; De Angelis G; Gallucci C; Alfieri C; Simone MD; Zinno F; Isacchi G; Adorno G; Lanti A; Leti W; Aiuti F; Fraboni D; Andreani M; Lucarelli G
    Biol Blood Marrow Transplant; 2010 Nov; 16(11):1557-66. PubMed ID: 20546907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reciprocal interaction between intestinal microbiota and mucosal lymphocyte in cynomolgus monkeys after alemtuzumab treatment.
    Li QR; Wang CY; Tang C; He Q; Li N; Li JS
    Am J Transplant; 2013 Apr; 13(4):899-910. PubMed ID: 23433407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential in vivo effects of rituximab on two B-cell subsets in cynomolgus monkeys.
    Vugmeyster Y; Howell K; McKeever K; Combs D; Canova-Davis E
    Int Immunopharmacol; 2003 Oct; 3(10-11):1477-81. PubMed ID: 12946444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subsets of CD3+ (T cell receptor alpha/beta or gamma/delta) and CD3- lymphocytes isolated from normal human gut epithelium display phenotypical features different from their counterparts in peripheral blood.
    Jarry A; Cerf-Bensussan N; Brousse N; Selz F; Guy-Grand D
    Eur J Immunol; 1990 May; 20(5):1097-103. PubMed ID: 2141568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interpreting Lymphocyte Reconstitution Data From the Pivotal Phase 3 Trials of Alemtuzumab.
    Baker D; Herrod SS; Alvarez-Gonzalez C; Giovannoni G; Schmierer K
    JAMA Neurol; 2017 Aug; 74(8):961-969. PubMed ID: 28604916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intraepithelial, lamina propria and Peyer's patch lymphocytes of the rat small intestine: isolation and characterization in terms of immunoglobulin markers and receptors for monoclonal antibodies.
    Lyscom N; Brueton MJ
    Immunology; 1982 Apr; 45(4):775-83. PubMed ID: 7040214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunophenotypic analysis of cellular infiltrate of renal allograft biopsies in patients with acute rejection after induction with alemtuzumab (Campath-1H).
    Gallon L; Gagliardini E; Benigni A; Kaufman D; Waheed A; Noris M; Remuzzi G
    Clin J Am Soc Nephrol; 2006 May; 1(3):539-45. PubMed ID: 17699257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical relevance of differential lymphocyte recovery after alemtuzumab therapy for multiple sclerosis.
    Cossburn MD; Harding K; Ingram G; El-Shanawany T; Heaps A; Pickersgill TP; Jolles S; Robertson NP
    Neurology; 2013 Jan; 80(1):55-61. PubMed ID: 23243077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytotoxic effects of the trifunctional bispecific antibody FBTA05 in ex-vivo cells of chronic lymphocytic leukaemia depend on immune-mediated mechanism.
    Boehrer S; Schroeder P; Mueller T; Atz J; Chow KU
    Anticancer Drugs; 2011 Jul; 22(6):519-30. PubMed ID: 21637160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cellular immune reconstitution after subcutaneous alemtuzumab (anti-CD52 monoclonal antibody, CAMPATH-1H) treatment as first-line therapy for B-cell chronic lymphocytic leukaemia.
    Lundin J; Porwit-MacDonald A; Rossmann ED; Karlsson C; Edman P; Rezvany MR; Kimby E; Osterborg A; Mellstedt H
    Leukemia; 2004 Mar; 18(3):484-90. PubMed ID: 14749699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antigen-driven induction of CD11c on intestinal intraepithelial lymphocytes and CD8+ T cells in vivo.
    Huleatt JW; Lefrançois L
    J Immunol; 1995 Jun; 154(11):5684-93. PubMed ID: 7751620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A major fraction of human intraepithelial lymphocytes simultaneously expresses the gamma/delta T cell receptor, the CD8 accessory molecule and preferentially uses the V delta 1 gene segment.
    Deusch K; Lüling F; Reich K; Classen M; Wagner H; Pfeffer K
    Eur J Immunol; 1991 Apr; 21(4):1053-9. PubMed ID: 1826884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alemtuzumab induces enhanced apoptosis in vitro in B-cells from patients with chronic lymphocytic leukemia by antibody-dependent cellular cytotoxicity.
    Nückel H; Frey UH; Röth A; Dührsen U; Siffert W
    Eur J Pharmacol; 2005 May; 514(2-3):217-24. PubMed ID: 15910809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IgA B lymphocytes and subpopulations of T lymphocytes in the intestinal villi of immunodeficient Wistar rats.
    Gonzalez Ariki S; Lopez MC; Roux ME
    Reg Immunol; 1992; 4(1):41-5. PubMed ID: 1571229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Presence of intestinal intraepithelial lymphocytes in mice with severe combined immunodeficiency disease.
    Croitoru K; Stead RH; Bienenstock J; Fulop G; Harnish DG; Shultz LD; Jeffery PK; Ernst PB
    Eur J Immunol; 1990 Mar; 20(3):645-51. PubMed ID: 1690660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term treatment of pigs with low doses of monoclonal antibodies against porcine CD4 and CD8 antigens.
    Lohse L; Nielsen J; Eriksen L
    APMIS; 2006 Jan; 114(1):23-31. PubMed ID: 16499657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Do the CD45RO+CD8+ intestinal intraepithelial T lymphocytes have the characteristics of memory cells?
    Ebert EC
    Cell Immunol; 1993 Apr; 147(2):331-40. PubMed ID: 8453675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in blood and spleen lymphocyte populations following antigen challenge in immature male chickens.
    Trout JM; Mashaly MM; Siegel HS
    Br Poult Sci; 1996 Sep; 37(4):819-27. PubMed ID: 8894226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aberrant T-lymphocytes in refractory coeliac disease are not strictly confined to a small intestinal intraepithelial localization.
    Verbeek WH; von Blomberg BM; Coupe VM; Daum S; Mulder CJ; Schreurs MW
    Cytometry B Clin Cytom; 2009 Nov; 76(6):367-74. PubMed ID: 19444812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The evolving role of alemtuzumab (Campath-1H) for immunosuppressive therapy in organ transplantation.
    Magliocca JF; Knechtle SJ
    Transpl Int; 2006 Sep; 19(9):705-14. PubMed ID: 16918530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.